Broker Forecast - Liberum Capital issues a broker note on GlaxoSmithKline PLC

Mon, 4th Nov 2019

Liberum Capital today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1890p (from 1510p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

FTSE 100 Latest
Value6,157.30
Change-83.06